US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.9325

-0.0103-1.09%

Volume:203.30K

Turnover:183.74K

Market Cap:3.27M

PE:-0.03

High:0.9349

Open:0.9349

Low:0.8744

Close:0.9428

52wk High:62.50

52wk Low:0.8744

Shares:3.50M

Float Shares:1.25M

Volume Ratio:0.95

T/O Rate:16.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-32.4560

EPS(LYR):-371.2241

ROE:-126.98%

ROA:-62.31%

PB:0.33

PE(LYR):0.00

Loading ...

Overview Company News Filings

Propanc Biopharma Q3 FY26 net loss narrows to USD 6.36 million; no revenue

Propanc Biopharma announces 1-for-25 reverse stock split

Propanc Biopharma implements 1-for-25 reverse stock split effective May 18

Propanc Biopharma Inc - Approves 1-for-25 Reverse Stock Split Effective May 18, 2026

THOMSON REUTERS

Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans

THOMSON REUTERS

BRIEF-Propanc Biopharma Inc - Files To Offer Resale Of Up To 15 Million Shares Of Common Stock By Selling Stockholder - SEC Filing

Propanc Biopharma Inc - Files to Offer Resale of up to 15 Mln Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS

Propanc Biopharma plans 1-for-10 to 1-for-30 reverse stock split

Propanc Biopharma signs multi-year collaboration with Spanish universities

Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration With the Universities of JaÉN and Granada, Spain

THOMSON REUTERS

Propanc Biopharma Inc. Files Draft Information Statement on Form PRE 14C

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PPCB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPCB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":0.9325,"timestamp":1789155032289,"preClose":0.9428,"halted":0,"volume":203301,"delay":0,"changeRate":-0.010924904539669045,"floatShares":1250100,"shares":3503100,"eps":-32.455997,"marketStatus":"Trading","change":-0.0103,"latestTime":"09-11 15:31:01 EDT","open":0.9349,"high":0.9349,"low":0.8744,"amount":183736.3485951,"amplitude":0.064171,"askPrice":0.935,"askSize":2927,"bidPrice":0.921,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-32.455997,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"listingDate":1743998400000,"exchange":"NASDAQ","adjPreClose":0.9428,"preHourTrading":{"tag":"盘前","latestPrice":0.9201,"preClose":0.9428,"latestTime":"09:28 EDT","volume":5379,"amount":4981.37496054,"timestamp":1789133297438,"change":-0.0227,"changeRate":-0.024077,"amplitude":0.042427},"postHourTrading":{"tag":"盘后","latestPrice":0.94,"preClose":0.9428,"latestTime":"19:43 EDT","volume":5512,"amount":5162.2691,"timestamp":1789083783900,"change":-0.0028,"changeRate":-0.00297,"amplitude":0.024289},"volumeRatio":0.945178},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","floatShares":1250100,"roa":"-62.31%","roe":"-126.98%","lyrEps":-371.224075,"volumeRatio":0.945178,"shares":3503100,"dividePrice":0,"high":0.9349,"amplitude":0.064171,"preClose":0.9428,"low":0.8744,"week52Low":0.8744,"pbRate":"0.33","week52High":62.5,"institutionHeld":0,"latestPrice":0.9325,"committee":-0.999317,"eps":-32.455997,"divideRate":0,"volume":203301,"delay":0,"ttmEps":-32.455997,"open":0.9349,"prevYearClose":13.415,"prevWeekClose":1.01,"prevMonthClose":1.35,"prevQuarterClose":1.5,"fiveDayClose":1.02,"twentyDayClose":1.22,"sixtyDayClose":1.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-18","symbol":"PPCB","defaultRemindTime":1779111000000,"type":"split","dateTimestamp":1779076800000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2025-01-29","symbol":"PPCB","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":60000,"toFactor":1,"ratio":60000},{"market":"US","date":"2023-05-23","symbol":"PPCB","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2020-11-19","symbol":"PPCB","defaultRemindTime":1605796200000,"type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2019-06-24","symbol":"PPCB","type":"split","dateTimestamp":1561348800000,"forFactor":500,"toFactor":1,"ratio":500}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PPCB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PPCB","date":"2026-09-10","current":-0.029049,"percent":0.522222,"low":-1.336323,"twenty":-0.269509,"median":-0.12657,"eighty":-0.041288,"high":-0.023125,"avg":-0.181523,"sd":0.191359,"marketCap":2255587},"quantilePoints":[{"date":"2025-04-04","current":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.050633,"marketCap":84546},{"date":"2025-04-07","current":-0.048332,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"marketCap":80703},{"date":"2025-08-22","current":-0.938461,"twenty":-0.969897,"median":-0.655598,"eighty":-0.050633,"marketCap":51812834},{"date":"2025-08-29","current":-0.721182,"twenty":-0.884372,"median":-0.710781,"eighty":-0.050633,"marketCap":39816759},{"date":"2025-09-05","current":-0.457673,"twenty":-0.820575,"median":-0.688821,"eighty":-0.213449,"marketCap":25268328},{"date":"2025-09-12","current":-0.457673,"twenty":-0.778969,"median":-0.631034,"eighty":-0.41283,"marketCap":25268328},{"date":"2025-09-19","current":-0.506214,"twenty":-0.755854,"median":-0.517772,"eighty":-0.439644,"marketCap":27948302},{"date":"2025-09-26","current":-0.418378,"twenty":-0.712861,"median":-0.510837,"eighty":-0.435021,"marketCap":23098825},{"date":"2025-10-03","current":-0.399917,"twenty":-0.699454,"median":-0.498124,"eighty":-0.407301,"marketCap":23564414},{"date":"2025-10-10","current":-0.408611,"twenty":-0.69067,"median":-0.457673,"eighty":-0.403395,"marketCap":24076684},{"date":"2025-10-17","current":-0.343407,"twenty":-0.669984,"median":-0.449583,"eighty":-0.385572,"marketCap":20234660},{"date":"2025-10-24","current":-0.321672,"twenty":-0.645772,"median":-0.432247,"eighty":-0.369488,"marketCap":18953985},{"date":"2025-10-31","current":-0.269509,"twenty":-0.610693,"median":-0.4245,"eighty":-0.343407,"marketCap":15880366},{"date":"2025-11-07","current":-0.241906,"twenty":-0.556142,"median":-0.418378,"eighty":-0.313847,"marketCap":14253909},{"date":"2025-11-14","current":-0.169965,"twenty":-0.518234,"median":-0.404264,"eighty":-0.269509,"marketCap":10014876},{"date":"2025-11-21","current":-0.174454,"twenty":-0.514536,"median":-0.397743,"eighty":-0.234995,"marketCap":11061584},{"date":"2025-11-28","current":-0.188344,"twenty":-0.512687,"median":-0.384703,"eighty":-0.189884,"marketCap":11942288},{"date":"2025-12-05","current":-0.173885,"twenty":-0.509912,"median":-0.372748,"eighty":-0.182127,"marketCap":11025501},{"date":"2025-12-12","current":-0.170028,"twenty":-0.504827,"median":-0.356448,"eighty":-0.174606,"marketCap":10780935},{"date":"2025-12-19","current":-0.151754,"twenty":-0.498818,"median":-0.343407,"eighty":-0.171335,"marketCap":9622255},{"date":"2025-12-26","current":-0.139108,"twenty":-0.496968,"median":-0.326019,"eighty":-0.170682,"marketCap":8820401},{"date":"2026-01-02","current":-0.113099,"twenty":-0.476627,"median":-0.315152,"eighty":-0.168873,"marketCap":7171266},{"date":"2026-01-09","current":-0.101254,"twenty":-0.460447,"median":-0.284723,"eighty":-0.163023,"marketCap":6420182},{"date":"2026-01-16","current":-0.074044,"twenty":-0.457673,"median":-0.262988,"eighty":-0.151375,"marketCap":4694858},{"date":"2026-01-23","current":-0.056065,"twenty":-0.453513,"median":-0.243754,"eighty":-0.138341,"marketCap":3554888},{"date":"2026-01-30","current":-0.058573,"twenty":-0.449352,"median":-0.223866,"eighty":-0.121547,"marketCap":3713923},{"date":"2026-02-06","current":-0.042554,"twenty":-0.442879,"median":-0.192195,"eighty":-0.107345,"marketCap":2698240},{"date":"2026-02-13","current":-0.048688,"twenty":-0.435021,"median":-0.182701,"eighty":-0.093848,"marketCap":3087140},{"date":"2026-02-20","current":-0.048657,"twenty":-0.431486,"median":-0.176899,"eighty":-0.077306,"marketCap":3214676},{"date":"2026-02-27","current":-0.046857,"twenty":-0.428606,"median":-0.174834,"eighty":-0.060466,"marketCap":3095731},{"date":"2026-03-06","current":-0.040376,"twenty":-0.424799,"median":-0.173681,"eighty":-0.05647,"marketCap":2667530},{"date":"2026-03-13","current":-0.029045,"twenty":-0.422077,"median":-0.17085,"eighty":-0.050499,"marketCap":1918972},{"date":"2026-03-20","current":-0.028085,"twenty":-0.419765,"median":-0.170682,"eighty":-0.048484,"marketCap":1855535},{"date":"2026-03-27","current":-0.034166,"twenty":-0.417079,"median":-0.169454,"eighty":-0.047319,"marketCap":2257270},{"date":"2026-04-02","current":-0.035336,"twenty":-0.413827,"median":-0.167383,"eighty":-0.04606,"marketCap":2334602},{"date":"2026-04-10","current":-0.031762,"twenty":-0.406872,"median":-0.16427,"eighty":-0.043866,"marketCap":2098425},{"date":"2026-04-17","current":-0.033628,"twenty":-0.399911,"median":-0.155654,"eighty":-0.041322,"marketCap":2221738},{"date":"2026-04-24","current":-0.036697,"twenty":-0.399457,"median":-0.149858,"eighty":-0.040438,"marketCap":2424475},{"date":"2026-05-01","current":-0.032141,"twenty":-0.39557,"median":-0.138149,"eighty":-0.039889,"marketCap":2123505},{"date":"2026-05-08","current":-0.029421,"twenty":-0.386441,"median":-0.123469,"eighty":-0.037064,"marketCap":1943760},{"date":"2026-05-15","current":-0.023125,"twenty":-0.382964,"median":-0.117367,"eighty":-0.035899,"marketCap":1527837},{"date":"2026-05-22","current":-0.078772,"twenty":-0.376009,"median":-0.107725,"eighty":-0.036443,"marketCap":1446323},{"date":"2026-05-29","current":-0.077406,"twenty":-0.376009,"median":-0.101254,"eighty":-0.036697,"marketCap":1421242},{"date":"2026-06-05","current":-0.075584,"twenty":-0.369488,"median":-0.094421,"eighty":-0.037013,"marketCap":1387801},{"date":"2026-06-12","current":-0.110645,"twenty":-0.369488,"median":-0.091369,"eighty":-0.037013,"marketCap":2031540},{"date":"2026-06-18","current":-0.077861,"twenty":-0.359056,"median":-0.091369,"eighty":-0.037215,"marketCap":1429602},{"date":"2026-06-26","current":-0.068755,"twenty":-0.347754,"median":-0.088611,"eighty":-0.037494,"marketCap":1262397},{"date":"2026-07-02","current":-0.178687,"twenty":-0.344276,"median":-0.088611,"eighty":-0.038576,"marketCap":3280854},{"date":"2026-07-10","current":-0.220877,"twenty":-0.343407,"median":-0.091369,"eighty":-0.03962,"marketCap":4055500},{"date":"2026-07-17","current":-0.1973,"twenty":-0.335582,"median":-0.096459,"eighty":-0.039946,"marketCap":3622609},{"date":"2026-07-24","current":-0.179928,"twenty":-0.32515,"median":-0.101254,"eighty":-0.040156,"marketCap":3303637},{"date":"2026-07-31","current":-0.129051,"twenty":-0.321672,"median":-0.106776,"eighty":-0.040305,"marketCap":2369505},{"date":"2026-08-07","current":-0.16876,"twenty":-0.316456,"median":-0.111872,"eighty":-0.040388,"marketCap":3098584},{"date":"2026-08-14","current":-0.151387,"twenty":-0.306023,"median":-0.120497,"eighty":-0.04047,"marketCap":2779612},{"date":"2026-08-21","current":-0.136497,"twenty":-0.295156,"median":-0.123158,"eighty":-0.040781,"marketCap":2506208},{"date":"2026-08-28","current":-0.276716,"twenty":-0.28152,"median":-0.125329,"eighty":-0.041146,"marketCap":5080767},{"date":"2026-09-04","current":-0.12657,"twenty":-0.273833,"median":-0.12719,"eighty":-0.041245,"marketCap":2323938},{"date":"2026-09-10","current":-0.122847,"twenty":-0.269509,"median":-0.12657,"eighty":-0.041288,"marketCap":2255587}],"updateTime":1789126653630},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPCB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635721507","title":"Propanc Biopharma Q3 FY26 net loss narrows to USD 6.36 million; no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2635721507","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635721507?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:31","pubTimestamp":1778794274,"startTime":"0","endTime":"0","summary":"Propanc Biopharma posted a net loss of USD 6.36 million for the quarter ended March 31, 2026, narrowing from USD 54.07 million a year earlier.Administration expense fell to USD 6.22 million from USD 53.07 million, primarily due to lower stock-based compensation and stock-based consulting costs.Research and development expense rose to USD 169,660 from USD 54,097 as work advanced on PRP toward a Phase 1b first-in-human study in 30-40 advanced solid-tumor patients.Cash totaled USD 443,702 at March 31, 2026, down from USD 12.09 million at June 30, 2025; net cash used in operating activities was USD 4.08 million for the nine months ended March 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the orig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL1p2Vzq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635188627","title":"Propanc Biopharma announces 1-for-25 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2635188627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635188627?lang=en_us&edition=fundamental","pubTime":"2026-05-14 17:34","pubTimestamp":1778751248,"startTime":"0","endTime":"0","summary":"Propanc Biopharma (PPCB) announced that its board of directors on March 16 approved a 1-for-25 reverse stock split of the company’s issued and outs...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-announces-1-for-25-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-announces-1-for-25-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635763426","title":"Propanc Biopharma implements 1-for-25 reverse stock split effective May 18","url":"https://stock-news.laohu8.com/highlight/detail?id=2635763426","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635763426?lang=en_us&edition=fundamental","pubTime":"2026-05-14 10:00","pubTimestamp":1778724013,"startTime":"0","endTime":"0","summary":"Propanc Biopharma to execute 1-for-25 reverse stock split, effective before market open May 18, 2026.Move targets Nasdaq $1 minimum bid requirement, supporting continued listing.Outstanding shares expected to fall to about 2,278,372 from about 56,959,280 as of May 6, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL3bdytL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00BKPKM429.USD","BK4585","SG9999014013.SGD","IE00BN0W2T93.GBP","BK4588","BK4112","BK4139","LU2210150020.SGD","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635763430","title":"Propanc Biopharma Inc - Approves 1-for-25 Reverse Stock Split Effective May 18, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635763430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635763430?lang=en_us&edition=fundamental","pubTime":"2026-05-14 10:00","pubTimestamp":1778724000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA9Q97FP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635631887","title":"Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2635631887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635631887?lang=en_us&edition=fundamental","pubTime":"2026-05-14 10:00","pubTimestamp":1778724000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA9Q97FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626430871","title":"BRIEF-Propanc Biopharma Inc - Files To Offer Resale Of Up To 15 Million Shares Of Common Stock By Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626430871","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626430871?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:33","pubTimestamp":1775856784,"startTime":"0","endTime":"0","summary":"BRIEF-Propanc Biopharma Inc - Files To Offer Resale Of Up To 15 Million Shares Of Common Stock By Selling Stockholder - SEC FilingApril 10  - Propanc Biopharma Inc PPCB.O:PROPANC BIOPHARMA INC - FILES TO OFFER RESALE OF UP TO 15 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDER - SEC FILINGSource text: []Further company coverage: PPCB.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626014370","title":"Propanc Biopharma Inc - Files to Offer Resale of up to 15 Mln Shares of Common Stock by Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626014370","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626014370?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:32","pubTimestamp":1775856753,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nFWN40T104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PPCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624873554","title":"Propanc Biopharma plans 1-for-10 to 1-for-30 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2624873554","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624873554?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:41","pubTimestamp":1775000465,"startTime":"0","endTime":"0","summary":"Propanc Biopharma board adopted resolutions March 16, 2026, later enacted via shareholder written consent.Plan calls for restricted stock grants totaling 30 million shares to officers, directors, service providers.Board authorized reverse stock split in range 1-for-10 to 1-for-30.Reverse split expected to cut common shares outstanding to about 2.1 million to 0.7 million from about 20.9 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL53XP0S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621306094","title":"Propanc Biopharma signs multi-year collaboration with Spanish universities","url":"https://stock-news.laohu8.com/highlight/detail?id=2621306094","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621306094?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:11","pubTimestamp":1774357879,"startTime":"0","endTime":"0","summary":"Propanc Biopharma (PPCB) announced that a multi-year joint research collaboration agreement has been established with the Universities of Jaen and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-signs-multi-year-collaboration-with-spanish-universities-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/propanc-biopharma-signs-multi-year-collaboration-with-spanish-universities-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621620830","title":"Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration With the Universities of JaÉN and Granada, Spain","url":"https://stock-news.laohu8.com/highlight/detail?id=2621620830","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621620830?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:45","pubTimestamp":1774356300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nTUA7CK3TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620782517","title":"Propanc Biopharma Inc. Files Draft Information Statement on Form PRE 14C","url":"https://stock-news.laohu8.com/highlight/detail?id=2620782517","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620782517?lang=en_us&edition=fundamental","pubTime":"2026-03-20 18:02","pubTimestamp":1774000956,"startTime":"0","endTime":"0","summary":"Propanc Biopharma shareholders authorized the issuance of restricted common stock to officers, directors and service providers, including 7 million shares to James Nathanielsz.The authorization includes 2 million shares each to Jeannine Kingsley and VivoPharm.Additional issuances include 2.5 million shares each to Sylva International and Brunson Chandler & Jones.Shareholders also authorized a reverse stock split of common stock at a ratio between 1-for-10 and 1-for-30.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Mar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL5Jb2b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":51,"code":"91000000","status":"200"}]}}